A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

NCT03035253 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: OMP-305B83
DRUG: FOLFIRI
DRUG: FOLFOX

Sponsor

OncoMed Pharmaceuticals, Inc.